Yunda Huang

Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa

Also affiliated with Infectious Disease Research Institute, Fred Hutch Cancer Center, Cancer Research Center

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 50 papers. Top paper: “Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition”.

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

New England Journal of Medicine(2021)10.1056/nejmoa2031738

N/A

6.2DataRank · unranked

547 citations

Peter B. Gilbert, Michal Juraska, David C. Montefiori, Lynn Morris, Shelly Karuna +40 more

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation

Scientific Reports(2021)10.1038/s41598-021-03154-6

N/A

3.8DataRank · unranked

80 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Analysis of the HIV Vaccine Trials Network 702 Phase 2b–3 HIV-1 Vaccine Trial in South Africa Assessing RV144 Antibody and T-Cell Correlates of HIV-1 Acquisition Risk

The Journal of Infectious Diseases(2022)10.1093/infdis/jiac260

N/A

1.1DataRank · unranked

50 citations

One Dintwe, Sheetal Sawant, Doug Grove, Yunda Huang, Holly Janes +43 more

Safety, tolerability, pharmacokinetics, and immunological activity of dual-combinations and triple-combinations of anti-HIV monoclonal antibodies PGT121, PGDM1400, 10-1074, and VRC07-523LS administered intravenously to HIV-uninfected adults: a phase 1 randomised trial

The Lancet HIV(2023)10.1016/s2352-3018(23)00140-6

N/A

1.1DataRank · unranked

33 citations

Sharon Mannheimer, Carmen A. Paez, Chenchen Yu, Theresa Gamble, Deborah Theodore +22 more

Robust antibody and cellular responses induced by DNA-only vaccination for HIV

JCI Insight(2020)10.1172/jci.insight.137079

N/A

1.0DataRank · unranked

49 citations

Srilatha Edupuganti, Yunda Huang, Xue Han, Marnie Elizaga, Edith Swann +23 more

Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

Nature Medicine(2022)10.1038/s41591-022-01953-6

N/A

0.731DataRank · unranked

130 citations

Yunda Huang, Allan C. deCamp, Shelly Karuna, Yuanyuan Zhang, Craig A. Magaret +42 more

High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials

Nature Communications(2023)10.1038/s41467-023-43384-y

N/A

0.515DataRank · unranked

22 citations

Bryan T. Mayer, Allan C. deCamp, Yunda Huang, Bo Zhang, Lindsay N. Carpp +28 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

PLoS Medicine(2024)10.1371/journal.pmed.1004329

N/A

0.438DataRank · unranked

16 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +29 more

A mixed methods investigation of implementation barriers and facilitators to a daily mobile phone sexual risk assessment for young women in Soweto, South Africa

PLoS ONE(2020)10.1371/journal.pone.0231086

N/A

0.434DataRank · unranked

17 citations

Stefanie Hornschuh, Mamakiri Khunwane, Lerato M. Makhale, Kennedy Otwombe, Cecilia Morgan +9 more

Risk of COVID-19 after natural infection or vaccination

EBioMedicine(2023)10.1016/j.ebiom.2023.104799

N/A

0.396DataRank · unranked

13 citations

Matthew B. Laurens, Ying Huang, Chenchen Yu, Thomas Martin, Carina A. Rodriguez +94 more

Safety, tolerability, pharmacokinetics, and neutralisation activities of the anti-HIV-1 monoclonal antibody PGT121.414.LS administered alone and in combination with VRC07-523LS in adults without HIV in the USA (HVTN 136/HPTN 092): a first-in-human, open-label, randomised controlled phase 1 trial

The Lancet HIV(2024)10.1016/s2352-3018(24)00247-9

N/A

0.381DataRank · unranked

11 citations

Christopher B. Hurt, Kathryn E. Stephenson, Yunda Huang, Carmen A. Paez, Chenchen Yu +95 more

Safety and pharmacokinetics of N6LS, a broadly neutralising monoclonal antibody for HIV: a phase 1, open-label, dose-escalation study in healthy adults

The Lancet HIV(2025)10.1016/s2352-3018(25)00041-4

N/A

0.335DataRank · unranked

8 citations

Katherine V. Houser, Martin R. Gaudinski, Alicia T. Widge, Seemal F. Awan, Cristina Carter +95 more

Adults on pre-exposure prophylaxis (tenofovir-emtricitabine) have faster clearance of anti-HIV monoclonal antibody VRC01

Nature Communications(2023)10.1038/s41467-023-43399-5

N/A

0.330DataRank · unranked

8 citations

Lily Zhang, Shelly Karuna, Philip Andrew, Michal Juraska, Joshua A. Weiner +18 more

Cross-protocol assessment of induction and durability of VISP/R in HIV preventive vaccine trial participants

PLOS Global Public Health(2023)10.1371/journal.pgph.0002037

N/A

0.312DataRank · unranked

7 citations

Xue Han, Shannon Grant, Esther Kwara, Bharathi Lakshminarayanan, Michael Stirewalt +9 more

Safety, pharmacokinetics, and neutralisation activity of PGDM1400LS, a V2 specific HIV-1 broadly neutralising antibody, infused intravenously or subcutaneously in people without HIV-1 in the USA (HVTN 140/HPTN 101 part A): a first-in-human, phase 1 randomised trial

The Lancet HIV(2025)10.1016/s2352-3018(25)00012-8

N/A

0.292DataRank · unranked

6 citations

Carmen A. Paez, Chenchen Yu, Shelly Karuna, Theresa Gamble, Maurine D. Miner +32 more

Enhanced and sustained biodistribution of HIV-1 neutralizing antibody VRC01LS in human genital and rectal mucosa

Nature Communications(2024)10.1038/s41467-024-54580-9

N/A

0.279DataRank · unranked

5 citations

Rena D. Astronomo, Yunda Huang, Sandeep Narpala, Madhu Prabhakaran, Philipp Mann +16 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

EClinicalMedicine(2025)10.1016/j.eclinm.2024.103054

N/A

0.269DataRank · unranked

5 citations

Asa Tapley, Aaron Hudson, Sufia Dadabhai, Bo Zhang, Nyaradzo Mgodi +93 more

Risk Factors Associated with HIV Acquisition in Males Participating in HIV Vaccine Efficacy Trials in South Africa

AIDS and Behavior(2023)10.1007/s10461-023-04025-z

N/A

0.208DataRank · unranked

3 citations

Fatima Laher, Athmanundh Dilraj, Philip Smith, Glenda Gray, Doug Grove +16 more

A Randomised Clinical Trial of the Safety and Pharmacokinetics of VRC07-523LS Administered via Different Routes and Doses (HVTN 127/HPTN 087)

medRxiv(2024)10.1101/2024.01.10.23299799

N/A

0.208DataRank · unranked

3 citations

Cynthia L. Gay, Shelly Karuna, Ollivier Hyrien, Timothy Skalland, Kenneth H. Mayer +28 more

Analysis of Antibody Markers as Immune Correlates of Risk of Severe COVID-19 in the PREVENT-19 Efficacy Trial of the NVX-CoV2373 Recombinant Protein Vaccine

Clinical Infectious Diseases(2025)10.1093/cid/ciaf558

N/A

0.104DataRank · unranked

1 citations

Yunda Huang, Ying Huang, Wayne Woo, Alice McGarry, Germán Áñez +37 more

Putting computational models of immunity to the test - an invited challenge to predict B. pertussis vaccination outcomes

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.09.04.611290

N/A

0.104DataRank · unranked

1 citations

Lisa Willemsen, Michael C. Anderson, Minori Aoki, Saonli Basu, Julie G. Burel +54 more

Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens

PLoS ONE(2024)10.1371/journal.pone.0310042

N/A

0.104DataRank · unranked

1 citations

Liana Wu, Yunda Huang, Aaron Hudson, Peter B. Gilbert, Brian D. Williamson

Putting computational models of immunity to the test—An invited challenge to predict B.pertussis vaccination responses

PLoS Computational Biology(2025)10.1371/journal.pcbi.1012927

N/A

0.104DataRank · unranked

1 citations

Lisa Willemsen, Michael C. Anderson, Minori Aoki, Saonli Basu, Julie G. Burel +54 more

VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.29.685411

N/A

0DataRank · unranked

1 citations

Lyle Curry, Nonhlanhla N. Mkhize, Elena Giorgi, Craig A. Magaret, Bronwen E. Lambson +44 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

UNC Libraries(2025)10.17615/19xw-z883

N/A

0DataRank · unranked

0 citations

José A. Hidalgo, Fatima Laher, John Hural, Nicole L. Yates, Caroline Brackett +40 more

Hybrid versus vaccine immunity of mRNA-1273 among people living with HIV in East and Southern Africa: a prospective cohort analysis from the multicentre CoVPN 3008 (Ubuntu) study

UNC Libraries(2025)10.17615/p4hj-9n46

N/A

0DataRank · unranked

0 citations

Jia Jin Kee, Mubiana Inambao, Essack Mitha, Dishiki Kalonji, William Brumskine +76 more

Plasmodium falciparum Parasitemia Does Not Diminish Neutralizing Antibody Responses After mRNA COVID-19 Booster Vaccination in HIV-infected Adults

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf398

N/A

0DataRank · unranked

0 citations

Millicent Achola, Jack Hutter, Grace Mboya, Walter Otieno, Jia Jin Kee +16 more

Neutralizing and binding antibodies are a correlate of risk of COVID-19 in the CoVPN 3008 study in people with HIV

Nature Communications(2025)10.1038/s41467-025-63948-4

N/A

0DataRank · unranked

1 citations

Bo Zhang, Caroline Brackett, Peter Elyanu, Asa Tapley, Sufia Dadabhai +95 more

Generating Survival Times Using Cox Proportional Hazards Models with Cyclic and Piecewise Time-Varying Covariates

Statistics in Biosciences(2020)10.1007/s12561-020-09266-3

N/A

0DataRank · unranked

8 citations

Yuanyuan Zhang, Zong Zhang, Peter B. Gilbert, Yunda Huang

Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature

Scientific Reports(2020)10.1038/s41598-020-69007-w

N/A

0DataRank · unranked

10 citations

Kelly E. Seaton, Michael S. Piepenbrink, John Hural, Paul Goepfert, Fatima Laher +11 more

Intramuscular and Intradermal Electroporation of HIV-1 PENNVAX-GP® DNA Vaccine and IL-12 Is Safe, Tolerable, Acceptable in Healthy Adults

Vaccines(2020)10.3390/vaccines8040741

N/A

0DataRank · unranked

27 citations

Stephen C. De Rosa, Marnie Elizaga, Yiwen Lu, Xue Han, Yunda Huang +21 more

Assessing Durability of Vaccine Effect Following Blinded Crossover in COVID-19 Vaccine Efficacy Trials

medRxiv(2020)10.1101/2020.12.14.20248137

N/A

0DataRank · unranked

25 citations

Jonathan Fintzi, Michael P. Fay, Holly Janes, Lindsey R. Baden, Hana M. El Sahly +25 more

Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials

EBioMedicine(2021)10.1016/j.ebiom.2020.103203

N/A

0DataRank · unranked

29 citations

Logashvari Naidoo, Lily Zhang, Lindsay N. Carpp, Erika Rudnicki, April K. Randhawa +18 more

Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans

npj Vaccines(2021)10.1038/s41541-021-00305-8

N/A

0DataRank · unranked

15 citations

Aaron Deal, Xue Han, Shuying S. Li, Ashley Clayton, Jack Heptinstall +25 more

Early Pro-Inflammatory Signal and T-Cell Activation Associate With Vaccine-Induced Anti-Vaccinia Protective Neutralizing Antibodies

Frontiers in Immunology(2021)10.3389/fimmu.2021.737487

N/A

0DataRank · unranked

7 citations

Shuhui Wang, Dan Li, Lindsay N. Carpp, Tong Zhang, Ying Liu +7 more

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

Research Square(2021)10.21203/rs.3.rs-862572/v1

N/A

0DataRank · unranked

10 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation

medRxiv(2021)10.1101/2021.09.09.21263049

N/A

0DataRank · unranked

2 citations

Oleg Borisov, Jia Jin Kee, Lindsay N. Carpp, Terri Wrin, Suqin Cai +14 more

High Asymptomatic Carriage With the Omicron Variant in South Africa

Clinical Infectious Diseases(2022)10.1093/cid/ciac237

N/A

0DataRank · unranked

81 citations

Asa Tapley, Jessica Andriesen, Ishen Seocharan, Leigh H. Fisher, Lisa Bunts +85 more

Immune Correlates Analysis of the PREVENT-19 COVID-19 Vaccine Efficacy Clinical Trial

medRxiv(2022)10.1101/2022.06.22.22276362

N/A

0DataRank · unranked

15 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Immune correlates analysis of the PREVENT-19 COVID-19 vaccine efficacy clinical trial

Nature Communications(2023)10.1038/s41467-022-35768-3

N/A

0DataRank · unranked

102 citations

Yunda Huang, David Benkeser, Lindsay N. Carpp, Germán Áñez, Wayne Woo +35 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

PLoS Pathogens(2023)10.1371/journal.ppat.1011469

N/A

0DataRank · unranked

56 citations

Anna Yssel, Haajira Kaldine, Rebecca T. van Dorsten, Amanda S. Woodward Davis, Nicolas Beaume +35 more

Pharmacokinetic serum concentrations of VRC01 correlate with prevention of HIV-1 acquisition

EBioMedicine(2023)10.1016/j.ebiom.2023.104590

N/A

0DataRank · unranked

33 citations

Yunda Huang, Shelly Karuna, Jack Heptinstall, Caroline Brackett, Kelvin Chiong +40 more

Discovery medicine – the HVTN's iterative approach to developing an HIV-1 broadly neutralizing vaccine

Current Opinion in HIV and AIDS(2023)10.1097/coh.0000000000000821

N/A

0DataRank · unranked

13 citations

Sam T. Robinson, Yunda Huang, Troy Martin

Application of the SLAPNAP statistical learning tool to broadly neutralizing antibody HIV prevention research

iScience(2023)10.1016/j.isci.2023.107595

N/A

0DataRank · unranked

6 citations

Craig A. Magaret, Shelly Karuna, Lindsay N. Carpp, Huub C. Gelderblom, Yunda Huang +3 more

Neutralization profiles of HIV-1 viruses from the VRC01 Antibody Mediated Prevention (AMP) trials

UNC Libraries(2023)10.17615/nx73-wv26

N/A

0DataRank · unranked

0 citations

John Hural, Ruwayhida Thebus, Amanda Eaton, Shelly Karuna, Myron S. Cohen +35 more

Predicting neutralization susceptibility to combination HIV-1 monoclonal broadly neutralizing antibody regimens

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.14.571616

N/A

0DataRank · unranked

0 citations

Liana Wu, Yunda Huang, Aaron Hudson, Peter B. Gilbert, Brian D. Williamson

Durability of Protection Against COVID-19 Through the Delta Surge for the NVX-CoV2373 Vaccine

Clinical Infectious Diseases(2024)10.1093/cid/ciae081

N/A

0DataRank · unranked

10 citations

Allyson Mateja, Michael P. Fay, Craig A. Magaret, Yunda Huang, Youyi Fong +8 more

COVID-19 Vaccine Efficacy in Participants With Weakened Immune Systems From 4 Randomized Controlled Trials

Clinical Infectious Diseases(2024)10.1093/cid/ciae192

N/A

0DataRank · unranked

6 citations

Jessica Tuan, Valeria D Cantos, Oladunni Adeyiga, Scott Mahoney, Ana M. Ortega‐Villa +25 more

Safety and pharmacokinetics of VRC07-523LS administered via different routes and doses (HVTN 127/HPTN 087): A Phase I randomized clinical trial

UNC Libraries(2024)10.17615/jk04-ea73

N/A

0DataRank · unranked

0 citations

Carlos del Rı́o, Adrian B. McDermott, Estelle Piwowar‐Manning, Timothy Skalland, Margaret E. Ackerman +29 more

Influence of the broadly neutralizing antibody VRC01 on HIV breakthrough virus populations in antibody-mediated prevention trials

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.07.01.659979

N/A

0DataRank · unranked

1 citations

Chivonne Moodley, Craig A. Magaret, Elena Giorgi, Morgane Rolland, Dylan H. Westfall +43 more